PRAVACHOL |
PRAVASTATIN |
C10AA03 |
(+)-(3R,5R)-3,5-DIHYDROXY-7-[(1S,2S,6S,8S,8AR)-6-HYDROXY-2-METHYL-8-{[(S)-2-METHYLBUTYRYL]OXY}-1,2,6,7,8,8A-HEXAHYDRO-1-NAPHTHYL]HEPTANOIC ACID |
PRAVACHOL® |
PRAVASTATINA |
PRAVASTATIN ACID |
LIPOSTAT® |
PRAVASTATIN SODIUM |
PRAVASTATINE |
PRAVASTATINUM |
chemidplus:81093-37-0 |
chembl:CHEMBL1144 |
drugbank:00175 |
rxcui:42463 |
pubchem.compound:54687 |
Drug Categories | hydroxymethylglutaryl-coa reductase inhibitors |
Drug Indications | anticholesterolaemic agent |
FDA Approval | approved |
Drug Class | Small Molecule |
Drug Indications | antihypecholesterolemic agent |
Drug Class | anticholesteremic agents |
Year of Approval | 1991 |
Drug Categories | agents causing muscle toxicity |
Drug Categories | bsep/abcb11 substrates |
Drug Categories | drugs causing inadvertant photosensitivity |
Drug Categories | hypolipidemic agents indicated for hyperlipidemia |
Drug Categories | lipid modifying agents, plain |
Drug Categories | oat1/slc22a6 inhibitors |
Drug Categories | oat3/slc22a8 inhibitors |
Drug Categories | oat3/slc22a8 substrates |
Drug Categories | oatp1b3 substrates |
Drug Categories | p-glycoprotein substrates |
Drug Categories | photosensitizing agents |
inhibitor (inhibitory) |
Trial Name | CRES pravastatin |
Novel drug target | Established target |
Trial Name | pravastatin and fenofibrate,PravaFen |
n/a |
Specific Action of the Ligand | Binding |
Endogenous Drug? | False |
Direct Interaction? | False |
PRAVASTATIN | DrugBank Drug Name |
81093-37-0 | CAS Number |
Ach-pravastatin | Drug Brand |
Drug Type | small molecule |
Drug Groups | approved |
Drug Categories | agents causing muscle toxicity |
PRAVASTATIN | Primary Drug Name |
Year of Approval | 1991 |
Drug Class | anticholesteremic agents |
Drug Indications | antihypecholesterolemic agent |
Drug Class | Small Molecule |
FDA Approval | approved |
C29375 | NCI drug code |
PRAVASTATIN | GuideToPharmacology Ligand Name |
D02RQU | TTD Drug ID |